Biohacking Market To Reach $67.86 Billion By 2030 | CAGR: 18.6%

Biohacking Market Growth & Trends

The global biohacking market size is anticipated to reach USD 67.86 billion by 2030, registering a CAGR of 18.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Various initiatives by market players and rising funds for biohacking are the major factors fueling the market growth. The adoption of biohacking practices is growing due to their potential applications in decreasing the risk of developing a disease, especially genetically associated diseases, helping an individual to achieve mental, physical, or emotional changes, such as weight loss or reducing depression symptoms; and optimize general functions of the body, such as blood pressure.

The global market has been significantly affected by the COVID-19 pandemic. Some of the major impacts of COVID-19 on the market include supply chain disruptions, a decline in sales, and low demand. However, biohackers in the industry are investing in some research activities for the development of COVID-19 vaccines as well as test kits. This neutralized the market growth in 2020. For the purchase of equipment and materials, biohackers require basic funding. Other than crowdfunding, most of the activities at these labs are self-funded through membership and workshop fees. Furthermore, private donations are also used for raising money.

Oura Health, manufacturer of the Oura ring, a sleep-improvement and sleep tracking platform, raised USD 20 million in Series B funding led by MSD Capital in December 2018. The global market is fairly competitive. Most of the market players have undertaken strategies, such as new product launches, acquisitions, and partnerships, to gain a competitive edge over each other. For instance, in September 2020, Apple Inc. partnered with the government of Singapore for launching a national health initiative using Apple Watch. With this, the country made an effort to leverage technology for delivering advanced health benefits to its citizens.

 Request a free sample copy or view report summary: Biohacking Market Report

Biohacking Market Report Highlights

• The wearables segment accounted for a share of 29.9% in 2023. Current developments in this market mainly focus on technological progress, such as adding additional health functions, incorporating Artificial Intelligence for personalized suggestions, and sending live data to healthcare professionals for prompt interventions and better patient results.

• The diagnosis and treatment segment held the largest revenue share of over 32.3% in 2023 due to the high usage of biohacking practices, such as nootropics and wearable technologies, for body enhancement purposes.

• The hospitals and clinics segment held the largest share of 40.3% in 2023. The segment growth is credited to the increase in chronic diseases and their treatment.

• North America biohacking market dominated the market in 2023 with a market share of 36.7%. This is due to the increasing prevalence of chronic illnesses, increase in the awareness of biohacking, and an aging population in the region.

• Asia Pacific Biohacking market is anticipated to witness significant growth in 2023 with a CAGR of 20.6% attributing to the rise in healthcare expenditure that has led to economic growth in the region.

Biohacking Market Segmentation

Grand View Research has segmented global biohacking market report based on product, application, end-use, and region:

Biohacking Product Outlook (Revenue, USD Million, 2018 - 2030)

• Wearables

  • Wearable Neurotech

  • Oura Ring

  • Muse Headband

  • Others

• Implants

  • Blood Test Implant

  • Circadia Implant

  • NFC and RFID Tags

  • Others

• Gene Modification Kits

• Smart Drugs

• Supplements

• Mobile Apps

• Others

Biohacking Application Outlook (Revenue, USD Million, 2018 - 2030)

• Synthetic Biology

• Genetic Engineering

• Forensic Science

• Diagnosis & Treatment

• Drug Testing

Biohacking End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies

• Hospitals & Clinics

• Forensic Laboratories

• Research & Academic Institutes

Biohacking Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Biohacking Market

• Apple Inc.

• The ODIN

• Thync Global Inc.

• Fitbit, Inc.

• Nuanic

• HVMN Inc.

• Muse (Interaxon Inc.)

• Thriveport, LLC

• OsteoStrong

• TrackMyStack